A sequence of pathologic events in a patient after thymectomy for myasthenia gravis.
The case of a rare coexistence of myasthenia gravis (MG) with systemic lupus erythematosus (SLE) is described. MG was diagnosed prior to SLE which developed after thymectomy. The patient was affected by HCV viremia. Therefore, there were therapeutic problems. Metylase treatment was continued for several years and dopamine receptor agonist was effectively administered as adjunctive therapy in SLE.
Hrycek
Antoni
A
Department of Internal, Autoimmune, and Metabolic Diseases, Medical University of Silesia, ul. Medyków 14, 40-752 Katowice, Poland. genmar@ka.onet.pl
D000328:Adult; D000634:Aminoquinolines / Q000627:therapeutic use; D000075202:Contraindications; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids; D016174:Hepacivirus; D006801:Humans; D007166:Immunosuppressive Agents; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D009157:Myasthenia Gravis / Q000601:surgery*; D013934:Thymectomy / Q000009:adverse effects*; D016896:Treatment Outcome; D014766:Viremia / Q000175:diagnosis* / Q000821:virology
D000634:Aminoquinolines; D018491:Dopamine Agonists; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; C046650:quinagolide